Applera Declares ABI Dividend | GenomeWeb

NEW YORK, April 24 (GenomeWeb News) - Applera said today that its board has declared a regular quarterly dividend of $0.0425 per share of the company's Applied Biosystems subsidiary.

 

The dividend is payable on July 3 to shareholders of record as of June 1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.